Aurobindo Pharma Limited has informed the Exchange regarding ‘Information under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015’.The Board of Directors of Aurobindo Pharma Limited ( the……
| Subscribe To Our Free Newsletter |
